A recent study published in Clinical Nutrition concludes that combining semaglutide (Ozempic) with a very low-calorie diet may be a more effective way to treat type 2 diabetes than either approaches in isolation
The rates are remarkably similar across all three, despite their different mechanisms: Semaglutide: Nausea approximately 18%, diarrhea approximately 12%, vomiting approximately 8% Tirzepatide: Nausea 17-22% (dose dependent), diarrhea 13-16%, vomiting 6-10% Retatrutide: Nausea 16-25% (dose dependent), diarrhea 15-22%, vomiting 8-13% The pattern holds consistently
While using semaglutide, monitor blood sugar levels, kidney function, and signs of pancreatitis
Because each of these factors can influence results, treatment decisions often depend on a patients full health history and weight loss goals